Medicare Enrolled
Dr. Mehran Taban, M.D.
Ophthalmology · Torrance, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Taban from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Taban?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Taban
Dr. Mehran Taban is an ophthalmology specialist in Torrance, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Taban performed 41,205 Medicare services across 9,182 unique beneficiaries.
Between the years covered by Open Payments, Dr. Taban received a total of $4,928 from 34 pharmaceutical and/or device companies across 143 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Taban is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 1% volume in CA
$4,928 industry payments
Medicare Practice Summary
Medicare Utilization ↗41,205
Medicare services
Top 1% in CA for ophthalmology
9,182
Unique beneficiaries
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,289 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) An injection of faricimab-svoa, a medication administered in 0.1 mg doses. |
6,720 | $29 | $100 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
5,232 | $33 | $139 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
4,546 | $98 | $445 |
| Compounded drug, not otherwise classified A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products. |
4,028 | $73 | $150 |
| Injection of drug into cavity behind eye A procedure where medication is injected into the space behind the eyeball. |
3,774 | $33 | $257 |
| Triamcinolone acetonide injection, 1 mg An injection of triamcinolone acetonide, a corticosteroid medication, administered in a 1 mg dose without preservatives. |
2,640 | $4 | $15 |
| Ultrasound of eye tissue and structures A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures. |
2,606 | $40 | $317 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
2,223 | $100 | $418 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
1,641 | $123 | $294 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
1,585 | $77 | $290 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
1,094 | $31 | $228 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
1,060 | $21 | $84 |
| Fluorescein angiography of the eye An imaging test of the front part of the eye using a special camera after a dye is injected to visualize blood flow. |
716 | $136 | $478 |
| Fluorescein angiography of retina A special camera captures images of the blood vessels in the retina and the area between the white part of the eye and the retina after a dye is injected. |
664 | $239 | $792 |
| Pegcetacoplan intravitreal injection, 1 mg An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram. |
450 | $120 | $400 |
| Retinal laser destruction of growth A laser procedure used to destroy abnormal growths in the retina. |
357 | $453 | $1,751 |
| Injection, ranibizumab, 0.1 mg | 310 | $179 | $800 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
305 | $121 | $542 |
| Aflibercept eye injection (Eylea) | 264 | $692 | $3,000 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
234 | $511 | $1,692 |
| Retinal laser treatment for leaking blood vessels This procedure uses a laser to seal leaking blood vessels in the retina. It is performed to prevent vision loss caused by fluid leakage from damaged retinal vessels. |
167 | $298 | $2,650 |
| Extended exam of back of eye with optic nerve drawing A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing. |
105 | $13 | $54 |
| Removal of recurring cataract in lens capsule A surgical procedure to remove a recurrent cataract by making a stab incision in the lens capsule. |
68 | $216 | $1,340 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
55 | $55 | $222 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
55 | $29 | $127 |
| Retinal detachment repair with fluid drainage A surgical procedure to reattach a detached retina by draining excess fluid from the space between the lens and the retina. |
53 | $1,039 | $3,320 |
| Removal of retinal membrane A surgical procedure to remove a membrane from the surface of the retina. |
41 | $558 | $3,849 |
| Bevacizumab injection, 10 mg Administration of a 10 mg dose of bevacizumab medication via injection. |
40 | $40 | $225 |
| Iris margin removal to improve eye fluid flow A surgical procedure to remove a portion of the iris margin. This is performed to improve the flow of fluid within the eye. |
37 | $191 | $1,445 |
| Laser vitreolysis A laser procedure used to destroy fluid in the vitreous of the eye, located between the lens and the retina. |
23 | $422 | $3,233 |
| Vitreous removal between lens and retina This procedure involves the removal of the vitreous fluid located between the lens and the retina of the eye. |
19 | $696 | $3,021 |
| Complex detached retina repair with eye fluid drainage A surgical procedure to repair a detached retina and drain fluid located between the lens and the retina. |
18 | $1,166 | $4,480 |
| Laser repair of detached retina A procedure that uses a laser to seal and reattach a detached retina to the back of the eye. |
17 | $266 | $1,003 |
| Removal of implanted eye lens This procedure involves the surgical removal of an artificial lens that has been implanted in the eye. |
15 | $352 | $2,651 |
| Retinal membrane and internal limiting membrane removal A surgical procedure to remove a membrane from the retina along with the internal limiting membrane of the retina. |
15 | $534 | $3,853 |
| Removal of implant material from inside of eye This procedure involves the surgical removal of implant material located within the interior of the eye. |
14 | $483 | $2,200 |
| Retinal photocoagulation for vascular growth This procedure uses laser light to destroy abnormal blood vessels located between the retina and the sclera. |
14 | $442 | $1,801 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,928
Total received (2018-2024)
Avg $704/year across 7 years
Top 25% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
143
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,928 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$785
2023
$994
2022
$602
2021
$992
2020
$340
2019
$806
2018
$411
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$331
Genentech USA, Inc.
$152
Apellis Pharmaceuticals, Inc.
$115
Ocular Therapeutix, Inc.
$64
ABBVIE INC.
$39
Biogen, Inc.
$32
Amgen Inc.
$27
Alimera Sciences, Inc.
$25
Top 3 companies account for 76.2% of 2024 payments
All-time payments by company (2018-2024) ›
Alcon Vision LLC
$1,768
Genentech USA, Inc.
$475
Astellas Pharma US Inc
$373
Allergan, Inc.
$235
Apellis Pharmaceuticals, Inc.
$212
OPTOS, INC.
$200
Alcon Laboratories Inc
$193
EyePoint Pharmaceuticals US, Inc.
$187
Regeneron Healthcare Solutions, Inc.
$127
Aerie Pharmaceuticals, Inc.
$121
Novartis Pharmaceuticals Corporation
$113
Bausch & Lomb, a division of Bausch Health US, LLC
$112
Alimera Sciences, Inc.
$104
Allergan Inc.
$97
Ocular Therapeutix, Inc.
$64
Genentech, Inc.
$64
Regeneron Pharmaceuticals, Inc.
$44
Carl Zeiss Meditec AG
$39
ABBVIE INC.
$39
Sun Pharmaceutical Industries Inc.
$35
Mallinckrodt Hospital Products Inc.
$35
Biogen, Inc.
$32
Mallinckrodt Enterprises LLC
$32
AbbVie Inc.
$30
Mallinckrodt LLC
$29
Amgen Inc.
$27
Carl Zeiss Meditec, Inc.
$23
Shire North American Group Inc
$21
Coherus Biosciences Inc.
$19
Horizon Therapeutics plc
$19
Eyevance Pharmaceuticals LLC
$17
Akorn, Inc.
$16
Bausch & Lomb Americas Inc.
$15
Halozyme Inc
$13
Top 3 companies account for 53.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BEOVU · BESIVANCE · BYOOVIZ · CIRRUS HD-OCT · COMBIGAN · Cimerli · Constellation · DEXTENZA · DUREZOL · DURYSTA · EYLEA · Flarex · HYLENEX RECOMBINANT · ILUVIEN · Iluvien · Izervay · LOTEMAX · LOTEMAX GEL · LOTEMAX SM · LUMIGAN · Lucentis · Monaco · NGENUITY · None Specified · OZURDEX · P200DTx · PROLENSA · Rhopressa · SUSVIMO · Simbrinza · Susvimo · Syfovre · TEPEZZA · VABYSMO · Vabysmo · XELPROS · XIIDRA · XIPERE · YUTIQ · Zioptan · rhopressa
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Ophthalmologists within 10 mi
719
Per 100K population
7.3
County median income
$87,760
Nearest hospital
PROVIDENCE LITTLE COMPANY OF MARY MED CTR TORRANCE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Taban is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Taban experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Taban performed 6,720 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Taban receive payments from pharmaceutical companies?
Yes. Dr. Taban received a total of $4,928 from 34 companies across 143 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Taban's costs compare to other ophthalmologists in Torrance?
Dr. Taban's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Taban) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Torrance
Browse ophthalmologists in Torrance ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in CA
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in CA
Which CA ophthalmologists receive the most from drug and device companies.
By company
Alcon Vision LLC Payments to Doctors
See all physicians who received payments from Alcon Vision LLC.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology